Deutsche Bank’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-361,534
| Closed | -$38.8M | – | 3992 |
|
|
2023
Q1 | $38.8M | Buy |
361,534
+344,368
| +2,006% | +$37M | 0.02% | 584 |
|
|
2022
Q4 | $1.89M | Buy |
17,166
+3,330
| +24% | +$366K | ﹤0.01% | 1695 |
|
|
2022
Q3 | $816K | Sell |
13,836
-1,406
| -9% | -$82.9K | ﹤0.01% | 2088 |
|
|
2022
Q2 | $430K | Sell |
15,242
-1,282
| -8% | -$36.2K | ﹤0.01% | 2685 |
|
|
2022
Q1 | $624K | Sell |
16,524
-1,690
| -9% | -$63.8K | ﹤0.01% | 2613 |
|
|
2021
Q4 | $720K | Buy |
18,214
+11,714
| +180% | +$463K | ﹤0.01% | 2598 |
|
|
2021
Q3 | $154K | Sell |
6,500
-209
| -3% | -$4.95K | ﹤0.01% | 3656 |
|
|
2021
Q2 | $165K | Buy |
+6,709
| New | +$165K | ﹤0.01% | 3845 |
|